CredoScientia - Bibliothèque

Stereotactic body radiation therapy for hepatocellular carcinoma: a comprehensive review.

Hepatocellular carcinoma (HCC) presents significant challenges in modern surgical and radiation oncology, primarily due to biological heterogeneity and the complexities of underlying liver cirrhosis. …

Thérapies de Conversion

Di, Y., Ren, G., Wang, Y., Meng, L., & Li, J. (2026). Stereotactic body radiation therapy for hepatocellular carcinoma: a comprehensive review.. Front Oncol, 16, 1747449. https://doi.org/10.3389/fonc.2026.1747449

01/01/2026 Lire →

Multimodal Conversion Therapy Enabling Curative Resection in Giant Hepatocellular Carcinoma with Arteriovenous Fistula: A Case Report.

BACKGROUND: Giant hepatocellular carcinoma (GHCC) with arteriovenous fistula (AVF) is often considered a surgical no-go zone, lacking a standardized conversion therapy. This paper reports a case in wh…

Thérapies de Conversion

Zhong, H., Tan, L., Le, W., Luo, N., Shen, Y., Long, G., Xiong, C., & Tao, H. (2026). Multimodal Conversion Therapy Enabling Curative Resection in Giant Hepatocellular Carcinoma with Arteriovenous Fistula: A Case Report.. J Hepatocell Carcinoma, 13, 599120. https://doi.org/10.2147/JHC.S599120

01/01/2026 Lire →

TACE Combined with Targeted Immunotherapy: A Strategy for Liver Transplantation Conversion and Survival Benefits in Patients with BCLC Stage B/C HCC.

BACKGROUND: Patients with BCLC stage B or C hepatocellular carcinoma (HCC) often face long waiting times. The effectiveness of different tumor control strategies remains unclear. This study evaluates …

Thérapies de Conversion

Zhang, H., Zhang, X., Zhang, L., Wang, S., & Ma, Y. (2026). TACE Combined with Targeted Immunotherapy: A Strategy for Liver Transplantation Conversion and Survival Benefits in Patients with BCLC Stage B/C HCC.. J Hepatocell Carcinoma, 13, 588533. https://doi.org/10.2147/JHC.S588533

01/01/2026 Lire →

The survival impact of upfront or sequential chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

BACKGROUND: The treatment of locally advanced unresectable esophageal squamous cell carcinoma (ESCC) is a clinical challenge with limited therapeutic consensus. The immune checkpoint inhibitor (ICI)-b…

Thérapies de Conversion

Luo, X., Peng, F., Lin, X., Li, Y., & Ding, Z. (2026). The survival impact of upfront or sequential chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.. Front Oncol, 16, 1785745. https://doi.org/10.3389/fonc.2026.1785745

01/01/2026 Lire →

Gastric cancer, what's new from International Gastric Cancer Congress (IGCC) in Amsterdam: a scientific report from Salerno 2025 conference.

This paper presents a critical synthesis of the national conference "Gastric Cancer at Ruggi d'Aragona", held in Salerno, Italy, in June 2025. The event gathered over 200 specialists to discuss recent…

Thérapies de Conversion

Cattel, D., Albano, P. V., Feo, R., Pepe, S., & Puzziello, A. (2026). Gastric cancer, what's new from International Gastric Cancer Congress (IGCC) in Amsterdam: a scientific report from Salerno 2025 conference.. Ecancermedicalscience, 20, 2083. https://doi.org/10.3332/ecancer.2026.2083

01/01/2026 Lire →

Hepatitis B virus infection and outcomes of TACE plus lenvatinib and PD-1 inhibitor therapy in unresectable hepatocellular carcinoma: a real-world propensity score-matched study.

BACKGROUND: The combination of transarterial chemoembolization (TACE), lenvatinib, and PD-1 inhibitors has shown promising efficacy in treating advanced hepatocellular carcinoma (HCC). However, the im…

Thérapies de Conversion

Su, Y., Liang, Y., Zhong, D., Chen, Y., Ma, S., Wang, M., Yang, Q., Yan, H., & Huang, X. (2026). Hepatitis B virus infection and outcomes of TACE plus lenvatinib and PD-1 inhibitor therapy in unresectable hepatocellular carcinoma: a real-world propensity score-matched study.. Front Immunol, 17, 1808956. https://doi.org/10.3389/fimmu.2026.1808956

01/01/2026 Lire →

TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study.

BACKGROUND: Most patients with hepatocellular carcinoma (HCC) are diagnosed at intermediate or advanced stages, when curative resection is not feasible. Conversion therapy aiming to downstage tumors a…

Thérapies de Conversion

Su, Y., Liang, Y., Zhong, D., Chen, Y., Wang, M., Yang, Q., Yan, H., & Huang, X. (2026). TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study.. Front Immunol, 17, 1802197. https://doi.org/10.3389/fimmu.2026.1802197

01/01/2026 Lire →

Efficacy of Bronchial Artery Infusion/Chemoembolization Combined with Platinum-Based Chemotherapy and PD-1 Inhibitor in Initially Unresectable Stage III Non-Small Cell Lung Cancer.

BACKGROUND: To evaluate the efficacy of bronchial arterial infusion/bronchial arterial chemoembolization (BAI/BACE) combined with platinum-based doublet chemotherapy and PD-1 inhibitor in patients wit…

Thérapies de Conversion

Quan, X., Lei, L., Chen, X., Jia, X., Wu, C., Ye, B., Huang, Q., Luo, M., Wang, N., Yu, J., & Feng, L. (2026). Efficacy of Bronchial Artery Infusion/Chemoembolization Combined with Platinum-Based Chemotherapy and PD-1 Inhibitor in Initially Unresectable Stage III Non-Small Cell Lung Cancer.. Cancer Manag Res, 18, 589356. https://doi.org/10.2147/CMAR.S589356

01/01/2026 Lire →

From centripetal to centrifugal: pathological regression patterns after neoadjuvant or conversion therapy as markers of nodal risk and a framework for future research on individualized lymphadenectomy in gastric cancer.

OBJECTIVE: To analyze the relationship between tumor regression patterns and ypN positivity and explore their implications for postoperative nodal-risk stratification after neoadjuvant or conversion t…

Thérapies de Conversion

Li, N., Liu, P., Guo, J., Wang, J., Zhao, G., Mou, Z., & Mao, J. (2026). From centripetal to centrifugal: pathological regression patterns after neoadjuvant or conversion therapy as markers of nodal risk and a framework for future research on individualized lymphadenectomy in gastric cancer.. Front Immunol, 17, 1766242. https://doi.org/10.3389/fimmu.2026.1766242

01/01/2026 Lire →

The Impact of Spatiotemporal Patterns of Tumor Recurrence on Prognosis in Hepatocellular Carcinoma Patients Undergoing Surgery After Conversion Therapy.

PURPOSE: To characterize the spatiotemporal patterns of recurrence and assess their impact on survival in hepatocellular carcinoma (HCC) patients undergoing curative resection after conversion therapy…

Thérapies de Conversion

Chen, Z., Zheng, H., Piao, M., Zhang, L., Sun, Y., Zhang, K., Zhang, J., Liu, Y., Xu, Y., & Lu, X. (2026). The Impact of Spatiotemporal Patterns of Tumor Recurrence on Prognosis in Hepatocellular Carcinoma Patients Undergoing Surgery After Conversion Therapy.. J Hepatocell Carcinoma, 13, 599046. https://doi.org/10.2147/JHC.S599046

01/01/2026 Lire →

Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report.

Massive hepatocellular carcinoma (HCC) is not suitable for radical surgery due to the factors of high tumor burden and poor postoperative liver function tolerance. There are few reports on the convers…

Thérapies de Conversion

Xu, R., Zhang, M., Zeng, Z., Wei, Y., Liao, X., Yang, C., Peng, T., & Su, H. (2026). Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report.. Pharmgenomics Pers Med, 19, 578577. https://doi.org/10.2147/PGPM.S578577

01/01/2026 Lire →

Successful conversion therapy of advanced gallbladder carcinoma by chemotherapy combined with immunotherapy: two case reports.

Gallbladder cancer (GBC) is a highly aggressive malignancy of the biliary system and is frequently diagnosed at an advanced stage upon initial presentation. Nonetheless, the introduction of conversion…

Thérapies de Conversion

Li, L., Tong, B., Gong, W., Xu, H., Liao, X., & Sun, H. (2026). Successful conversion therapy of advanced gallbladder carcinoma by chemotherapy combined with immunotherapy: two case reports.. Front Oncol, 16, 1758176. https://doi.org/10.3389/fonc.2026.1758176

01/01/2026 Lire →